STERIS plc (STE) is not a strong buy at the moment for a beginner, long-term investor. While the company shows solid financial growth in revenue, net income, and EPS, the technical indicators and options data suggest a neutral to slightly bearish sentiment. Additionally, there are no significant trading trends or recent news catalysts to support an immediate buy decision.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 54.166, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its first resistance level (R1: 224.931) with limited upside potential in the short term.

The company's financials for Q3 2026 show strong YoY growth in revenue (+9.17%), net income (+11.16%), and EPS (+12.00%), which is a positive indicator for long-term performance.
Gross margin dropped by -1.62% YoY, indicating potential cost pressures. Additionally, there are no significant trading trends, news catalysts, or recent activity from influential figures to drive short-term momentum.
In Q3 2026, STERIS plc reported revenue of $1.496 billion (+9.17% YoY), net income of $192.9 million (+11.16% YoY), and EPS of $1.96 (+12.00% YoY). However, gross margin declined to 43.81% (-1.62% YoY).
Morgan Stanley maintained an Equal Weight rating on the stock and slightly raised the price target to EUR 10.90 from EUR 10.70, indicating a neutral stance from analysts.